Bilberry Safety During Pregnancy
Bilberry should be avoided during pregnancy due to insufficient safety data, despite its lack of proven direct toxicity. While research shows no evidence of toxic compounds in bilberry fruits themselves, there is a critical absence of reproductive toxicity data, placental transfer information, and human pregnancy outcomes needed to recommend its use during pregnancy 1, 2.
Evidence Assessment
Lack of Pregnancy-Specific Safety Data
The most recent phytochemical analysis of bilberry (Vaccinium uliginosum and Vaccinium myrtillus) found no toxic alkaloids or harmful secondary metabolites in laboratory testing 1. However, this study used cell cultures and C. elegans models—not pregnant women or reproductive toxicity models. The absence of evidence of harm is not the same as evidence of safety in pregnancy.
A comprehensive 2022 review on herbal medicines in pregnancy specifically noted that for most herbal products, including those in the Vaccinium family, data regarding reproductive toxicity, placental crossing, and excretion in breast milk are lacking or incomplete 2. This creates an unacceptable knowledge gap for pregnancy use.
The Herbal Medicine Safety Problem
A large 2023 cohort study of 199,710 pregnancies in China revealed a concerning pattern: 65.71% used herbal medicines, with peak usage occurring between 5-10 weeks of gestation (the critical period of organogenesis). Yet systematic review of the top 100 herbal medicines showed that safety profiles were "mostly unclear or incomplete," with information lacking about reproductive toxicity, placental transfer, and breast milk excretion 3. While this study didn't specifically examine bilberry, it illustrates the broader problem of herbal medicine use in pregnancy without adequate safety data.
Bioactive Components Raise Concerns
Bilberry contains high concentrations of anthocyanins and other phenolic compounds that demonstrate significant biological activity:
- Cellular effects: Bilberry anthocyanins upregulate oxidative stress defense enzymes (HO-1 and GST-pi) and modulate cellular signaling pathways 4
- Mast cell modulation: Anthocyanins inhibit mast cell degranulation 5
- Processing matters: Thermal processing converts anthocyanins to anthocyanidins, altering biological activity 6, 5
These pharmacologically active compounds could theoretically affect fetal development, though this has not been studied in pregnancy.
Clinical Recommendation Algorithm
For any pregnant patient asking about bilberry:
- Advise against use due to insufficient pregnancy safety data
- Identify the intended purpose (e.g., urinary tract symptoms, vision support, antioxidant supplementation)
- Offer evidence-based alternatives with established pregnancy safety profiles
- Document the discussion in the medical record
Key Caveats
- Dietary consumption vs. supplementation: Occasional consumption of bilberries as food is likely low-risk, but concentrated extracts or supplements contain much higher doses of bioactive compounds
- No guideline coverage: Major pregnancy guidelines (AGA 2024, EASL 2023) do not address bilberry, reflecting the lack of clinical evidence 7, 8
- Patient perception: Many patients believe "natural" equals "safe"—this requires direct counseling that herbal products contain pharmacologically active compounds
- First trimester is highest risk: The critical period of organogenesis (weeks 5-10) coincides with when herbal medicine use peaks 3
Common Pitfall to Avoid
Do not assume that the absence of reported adverse events means bilberry is safe in pregnancy. The lack of systematic surveillance and reporting mechanisms for herbal products means adverse effects may go undetected. The precautionary principle applies: without adequate safety data, avoid use during pregnancy.